about
Radioimmunotherapy with α-particle-emitting radionuclides.Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosisRadioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.Crosstalk between Apoptosis and Autophagy is Regulated by the Arginylated BiP/Beclin-1/p62 Complex.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radioimmunotherapy for peritoneal cancers.
@en
type
label
Radioimmunotherapy for peritoneal cancers.
@en
prefLabel
Radioimmunotherapy for peritoneal cancers.
@en
P2860
P356
P1433
P1476
Radioimmunotherapy for peritoneal cancers.
@en
P2093
Christof Seidl
Markus Essler
P2860
P304
P356
10.2217/IMT.13.20
P577
2013-04-01T00:00:00Z